Physician profile
Rene Boudreau
NPI 1093691131
$77,620.39
in general payments reported to CMS, 2019-2025
5 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $77K · Food and Beverage: $327 · Education: $185 · Travel and Lodging: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $77,000.00 |
| Food and Beverage | $326.65 |
| Education | $184.60 |
| Travel and Lodging | $109.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50,066.03 | 2025 | General - Atherectomy, Avvigo Guidance System, Rotapro |
| Abbott Laboratories | $27,000.00 | 2025 | Xience V |
| Medtronic, INC. | $275.20 | 2025 | Resolute Onyx |
| Asahi Intecc USA, INC. | $234.47 | 2025 | Asahi Coronary Wires |
| Amgen INC. | $44.69 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Boudreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.